Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg
- 1 March 2005
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 86 (3) , 601-610
- https://doi.org/10.1099/vir.0.80575-0
Abstract
The purpose of this work was to assess the ability of plasmid DNA encoding hepatitis B virus (HBV) HBsAg encapsulated in poly(dl-lactide-co-glycolic acid) (PLGA) microparticles to induce local and systemic HBsAg-specific immunity following a single dose of oral immunization. RT-PCR analysis demonstrated prolonged transcription of plasmid DNA, consistent with the sustained expression and presentation of target antigen observed by confocal laser scanning microscopy, in gut-associated lymphocyte tissue (GALT) from mice immunized orally with plasmid DNA encapsulated into PLGA microparticles. Oral administration of PLGA-DNA microparticles induced a long-lasting and stable antigen-specific antibody response, both serum total antibody and intestinal IgA, in BALB/c mice. Mice immunized orally exhibited antigen-specific gamma interferon production and cytotoxic T lymphocyte responses in spleen and GALT after restimulationin vitrowith HBsAg or tumour cells stably expressing HBsAg. In contrast, naked DNA vaccines given by intramuscular injection induced only systemic cellular and humoral responses to HBsAg, which were much lower than the responses elicited by oral DNA encapsulated in PLGA microparticles at equivalent doses. The results are encouraging with regard to obtaining good compliance and vaccination coverage with candidate plasmid DNA vaccines, especially in developing countries.Keywords
This publication has 30 references indexed in Scilit:
- Thermo and pH responsive polymers as gene delivery vectors: effect of polymer architecture on DNA complexation in vitroJournal of Controlled Release, 2004
- Charged polylactide co-glycolide microparticles as antigen delivery systemsExpert Opinion on Biological Therapy, 2004
- Mucosal and Systemic Immune Responses to a Human Immunodeficiency Virus Type 1 Epitope Induced upon Vaginal Infection with a Recombinant Influenza A VirusJournal of Virology, 2004
- Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectorsExpert Opinion on Biological Therapy, 2003
- Protection of Tree Shrews by pVAX-PS DNA Vaccine against HBV InfectionDNA and Cell Biology, 2003
- Prime‐Boost Immunization with DNA and Modified Vaccinia Virus Ankara Vectors Expressing Herpes Simplex Virus–2 Glycoprotein D Elicits Greater Specific Antibody and Cytokine Responses than DNA Vaccine AloneThe Journal of Infectious Diseases, 2002
- Mechanism and therapeutic potential of DNA‐based immunization against the envelope proteins of hepatitis B virus in normal and transgenic miceImmunology, 2001
- Hepatitis B Virus-Specific T–Cell Proliferation and Cytokine Secretion in Chronic Hepatitis B E Antibody-Positive Patients Treated With Ribavirin and Interferon AlfaHepatology, 2001
- Vaccination of Seronegative Volunteers with a Human Immunodeficiency Virus Type 1env/revDNA Vaccine Induces Antigen‐Specific Proliferation and Lymphocyte Production of β‐ChemokinesThe Journal of Infectious Diseases, 2000
- Biodegradable Microspheres in Drug DeliveryCritical Reviews in Therapeutic Drug Carrier Systems, 1995